465b720e D68d 4903 Ad9c 1174af923f41 01
Trimethobenzamide Hydrochloride Capsule
Product Images NDC 43386-660
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Trimethobenzamide Hydrochloride (NDC 43386-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
465b720e D68d 4903 Ad9c 1174af923f41 02
465b720e D68d 4903 Ad9c 1174af923f41 03
NDC 43386-660-24 Trimethobenzamide Hydrochloride Capsules are prescribed medication that should be kept in a tightly sealed container away from children. These capsules should be stored within a controlled room temperature environment. Dosage instructions recommend that one capsule be taken three to four times daily by adults. The medication is manufactured by Hovel Laboratories in Somerset, NJ, and distributed by Lupin Pharmaceuticals in Baltimore, MD. The accompanying prescription information should be reviewed before taking.*
465b720e D68d 4903 Ad9c 1174af923f41 04
This is a description of a medication called Digense, identified by its national drug code (NDC) 43386-660-26. It is a capsule form of Trimethobenzamide Hydrochloride, used for the treatment of nausea and vomiting. There are 500 capsules in a container labeled for prescription use only. The manufacturer is Lupin Pharmaceuticals.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
